Press Releases for qcor

Press Releases
Free Research Reports on ALIM, DANG, QCOR and RVLT Issued by the Paragon Report
Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare Conference
Questcor Reports First Quarter Financial Results
Questcor to Report First Quarter Results on April 30, 2013
Free Research Reports on APOL, IVR, MNKD and QCOR Issued by the Bedford Report
Morning Research on Amgen, Affymax, Vertex Pharma, Questcor Pharma, and Repros Therapeutics
Free Research Reports on CBLI, DRYS, HALO and QCOR Issued by the Bedford Report
Perfect Trade Setups, How to Play NOK, QCOR, MPW and FTE
The Reason It Trades, What's Moving ZNGA, AA, FSLR and QCOR
A Forward Look, The Year Ahead - Research Report on Questcor Pharmaceuticals Inc., Actavis Inc., American International Group Inc., ACE Limited and Flowers Foods, Inc.
Drug Approvals, Increased R&D and Strong Product Portfolios Driving New Growth - Research Report on Medivation, MannKind, Questcor Pharmaceuticals, Charles River Laboratories and Peregrine Pharmaceuticals
Perfect Trade Setups, How to Play THC, AA, MPW and QCOR
R&D Investments, Pending Approvals, Acquisitions - Research Report on Optimer, Zogenix, Cubist, Merck and Questcor
The Real Story Behind IBM, QCOR, CRM and PM
Free Research Reports on GPOR, OPEN, QCOR and VHC Issued by the Bedford Report
Questcor Reports Fourth Quarter and Full Year 2012 Results
Free Research Report on Acuity Brands, Inc. (Holding Company), Questcor Pharmaceuticals, Inc., Casey's General Stores, Inc., MWI Veterinary Supply, Inc. and Community Bank System, Inc.
Shareholder Rights Law Firm Johnson & Weaver, LLP is Appointed by the United States District Court to Pursue Claims for the Benefit of Questcor and Its Shareholders
Questcor to Report Fourth Quarter and Full Year 2012 Financial Results on February 26, 2013
Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements
Questcor Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Questcor Pharmaceuticals to Acquire BioVectra Inc.
Should Recent Insider Selling on QCOR, INTU, SLG and IBKR Matter to You?
Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
Questcor and Child Neurology Foundation Support the 4th Annual Infantile Spasms Awareness Week
Questcor Teams With Child Neurology Foundation To Continue Funding Infantile Spasms Scientific Research
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Questcor Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of November 26, 2012 to Seek a Lead Plaintiff Position -- QCOR
Pomerantz Law Firm Reminds Shareholders of Questcor Pharmaceuticals, Inc. of Upcoming Deadline -- QCOR
Levi & Korsinsky, LLP Announces Investigation of Kayak Software Corporation (KYAK) and JDA Software Group Inc. (JDAS) and Class Action Against Questcor Pharmaceuticals, Inc. (QCOR) and Peregrine Pharmaceuticals, Inc. (PPHM)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of The Warnaco Group, Inc. (WRC) and Class Action Against Questcor Pharmaceuticals, Inc. (QCOR), Peregrine Pharmaceuticals, Inc. (PPHM) and Digital Domain Media Group, Inc. (DDMGQ)
Pomerantz Law Firm Reminds Shareholders of Questcor Pharmaceuticals, Inc. of Upcoming Deadline - QCOR
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of DUSA Pharmaceuticals Inc. (DUSA), Schiff Nutrition International, Inc. (SHF) and The Warnaco Group, Inc. (WRC) and Class Action Against Questcor Pharmaceuticals, Inc. (QCOR)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Questcor Pharmaceuticals, Inc. (QCOR) and Investigation of Metropolitan Health Networks, Inc. (MDF), KBW Inc. (KBW) and Sprint Nextel Corporation (S)
Lieff Cabraser Reminds Questcor Pharmaceuticals, Inc. Investors of Upcoming Deadline in Class Action Lawsuits
Pomerantz Law Firm Reminds Shareholders of Questcor Pharmaceuticals, Inc. of Upcoming Deadline - QCOR
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Ubiquiti Networks, Inc. (UBNT) and Questcor Pharmaceuticals, Inc. (QCOR) and Investigation of Cascade Corporation (CASC) and Cymer Inc. (CYMI)
Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline in the Class Action Lawsuit against Questcor Pharmaceuticals, Inc.
Pittsburgh Law Office of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf of Shareholders of Questcor Pharmaceuticals (QCOR) and Announces Investigations of Assisted Living Concepts (ALC), Blyth (BTH), Cymer (CYMI), Feihe International (NYSE: ADY), OCZ Technology Group (OCZ), Peregrine Pharmaceuticals (PPHM) and Union Drilling (UDRL)
Law Offices of Todd M. Garber Announces An Expanded Class Period of April 4, 2011 Through September 21, 2012 in the Shareholder Lawsuit Against Questcor Pharmaceuticals, Inc.
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Questcor Pharmaceuticals, Inc. With Expanded Class Period
Robbins Geller Rudman & Dowd LLP Files Expanded Class Period Class Action Suit against Questcor Pharmaceuticals, Inc.
Morgan & Morgan Reminds Shareholders of Questcor Pharmaceuticals, Inc. of Upcoming Deadline -- QCOR
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Questcor Pharmaceuticals, Inc. (QCOR), OCZ Technology Group, Inc. (OCZ), Ubiquiti Networks, Inc. (UBNT) and Peregrine Pharmaceuticals, Inc. (PPHM)
Questcor to Report Third Quarter Results on October 23, 2012
Pomerantz Law Firm Reminds Shareholders of Questcor Pharmaceuticals, Inc. of Upcoming Deadline -- QCOR
Levi & Korsinsky Notifies Investors With Losses on Their Investment in Questcor Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of November 26, 2012 to Seek a Lead Plaintiff Position
Free Reports on Alcoa, Glu Mobile, James River Coal, and Questcor Provided by the Bedford Report
Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against Questcor Pharmaceuticals, Inc.
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess of $100,000 Investing In Questcor Pharmaceuticals, Inc. To Contact the Firm
Wolf Haldenstein Adler Freeman & Herz LLP Commences Class Action Lawsuit on Behalf of Questcor Pharmaceuticals, Inc. Investors
Shareholder Class Action Filed Against Questcor Pharmaceuticals, Inc., By The Law Firm Of Kessler Topaz Meltzer & Check, LLP
Pomerantz Law Firm Has Filed a Class Action Against Questcor Pharmaceuticals, Inc. -- QCOR
Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Questcor Pharmaceuticals, Inc.
Holzer Holzer & Fistel, LLC Announces That It Has Filed a Class Action Lawsuit on Behalf of Investors in Questcor Pharmaceuticals, Inc.; Reminds Investors With Large Losses of Approaching Lead Plaintiff Deadline
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Questcor Pharmaceuticals, Inc.
Newman Ferrara LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Questcor Pharmaceuticals, Inc.
Law Offices of Howard G. Smith Announces Investigation of Questcor Pharmaceuticals, Inc.
Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Questcor Pharmaceuticals, Inc.
Brower Piven Encourages Investors Who Have Losses in Excess of $250,000 from Investment in Questcor Pharmaceuticals, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before The November 26, 2012 Lead Plaintiff Deadline
Pittsburgh Law Office of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf of Shareholders of Ubiquity Networks (UBNT) and Announces Investigations of American Greetings Corp. (AM), American Realty Capital Trust (ARCT), Audience (ADNC), Questcor Pharmaceuticals (QCOR), Sealy Corporation (ZZ), and West Coast Bancorp (WCBO)
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses in Excess of $100,000 Investing In Questcor Pharmaceuticals, Inc. To Contact the Firm
Glancy Binkow & Goldberg LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Questcor Pharmaceuticals, Inc.
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR)
Questcor Pharmaceuticals Initiates Quarterly Cash Dividend and Expands Stock Repurchase Program
Shareholder Rights Law Firm Johnson & Weaver, LLP Investigates Questcor Pharmaceuticals Inc. for Securities Fraud
Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Questcor Pharmaceuticals, Inc.
Questor Pharmaceuticals Stock Plummet Causes Shareholder Investigation by Goldfarb LLP Securities Lawyers
Robbins Umeda LLP Announces an Investigation of Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals Investor Alert - The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation for Possible Violations of Securities Laws
Holzer Holzer & Fistel, LLC Announces Investigation into Questcor Pharmaceuticals, Inc.
INVESTOR ALERT: Former Attorney General of Louisiana and Kahn Swick & Foti, LLC Investigate Questcor Pharmaceuticals, Inc. Following Report of Federal Investigation into Marketing; Massive Share Price Decline
Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
Questcor to Conduct Conference Call to Discuss Reimbursement Process
Questcor Comments on Insurance Policy Bulletin
Law Firm of Wohl & Fruchter LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
Questcor and The Myositis Association Team Up To Support Research and Educational Initiatives in Polymyositis and Dermatomyositis
Questcor Pharmaceuticals to Present at Investor Conferences in September
Questcor to Report Second Quarter Results on July 24, 2012
Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
Equities Lead Investor Sentiment - Research Report on Questcor Pharmaceuticals, Inc. and Eastman Chemical Company
Questcor Announces Initial Commercialization Plans for Acthar Rheumatology Indications
Questcor Announces Conference Call and Webcast on June 14, 2012 to Review Commercialization Strategy for Rheumatology Indications for Acthar
Calender of Events - Report Highlights Questcor Pharmaceuticals, Inc. and Eastman Chemical Company
Questcor Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
Questcor Pharmaceuticals Expands Repurchase Program
Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2012 Health Care Conference
Questcor Reports First Quarter 2012 Financial Results
Questcor to Report First Quarter 2012 Earnings and Conduct Conference Call on April 24, 2012
Questcor Pharmaceuticals to Present at the 24th Annual ROTH Conference on March 12, 2012
Conditions of Growth, Economic Analysis - Research Report on Questcor Pharmaceuticals, Inc. and Dendreon Corporation
Questcor Pharmaceuticals to Present at the Citigroup Global Health Care Conference on February 27, 2012
Questcor Reports Fourth Quarter and Full Year 2011 Financial Results
Questcor Recognized by Child Neurology Foundation for Outstanding Corporate Responsibility and Leadership
Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors
Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012
Questcor Announces Preliminary Fourth Quarter and Full Year 2011 Net Sales and Operating Income
Direction of Market Influences - Report Highlights Questcor Pharmaceuticals, Inc. and Perrigo Company
Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011